Measuring brain activity with a modified commercial virtual reality headset

Researchers have modified a commercial virtual reality headset, giving it the ability to measure brain activity and examine how we react to hints, stressors and other outside forces.

MSOS stock and what to expect next with MSOS stock

September 12, 2023

Novo Nordisk signs $1.46bn deal to develop molecular glue therapies

Share this article The Novo Nordisk and Neomorph deal is worth approximately $1.46bn in upfront and milestone-based payments across multiple targets. Image Credit: JHVEPhoto /

February 27, 2024

Navigating Change: What’s Ahead for Pharma in 2024

The world of pharmaceuticals is in for a big shake-up this year. A bunch of changes in healthcare is forcing the drug industry to rethink

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.